GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Euroapi SA (XPAR:EAPI) » Definitions » Other Gross PPE

Euroapi (XPAR:EAPI) Other Gross PPE : €10.6 Mil (As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Euroapi Other Gross PPE?

Euroapi's Other Gross PPE for the quarter that ended in Dec. 2024 was €10.6 Mil.

Euroapi's quarterly Other Gross PPE increased from Dec. 2023 (€8.8 Mil) to Jun. 2024 (€10.3 Mil) and increased from Jun. 2024 (€10.3 Mil) to Dec. 2024 (€10.6 Mil).

Euroapi's annual Other Gross PPE increased from Dec. 2022 (€6.8 Mil) to Dec. 2023 (€8.8 Mil) and increased from Dec. 2023 (€8.8 Mil) to Dec. 2024 (€10.6 Mil).


Euroapi Other Gross PPE Historical Data

The historical data trend for Euroapi's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Euroapi Other Gross PPE Chart

Euroapi Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Gross PPE
Get a 7-Day Free Trial 1,507.20 631.70 6.80 8.80 10.60

Euroapi Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Other Gross PPE Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.80 8.50 8.80 10.30 10.60

Euroapi Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.


Euroapi Business Description

Traded in Other Exchanges
Address
15 rue Traversiere, Paris, FRA, 75012
Euroapi SA develops, manufactures, markets, and distributes Active Pharmaceutical Ingredients (APIs) and Intermediates used in the formulation of medicines for human and veterinary use, both from originators, generics, and cosmetics. The company offers vitamin B12, prostaglandins, oligonucleotides, peptides, corticoids and hormones, anti-infectives, opiates (morphine, codeine, thebaine, etc.), analgesics, etc. It also offers Contract Development Manufacturing Organization (CDMO) services to its customers. Geographically, the company generates maximum revenue from Europe, followed by North America, Asia-Pacific, and the Rest of the world.

Euroapi Headlines

No Headlines